Also known as: 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, 1H-Purine-2,6-dione, 3,9-dihydro-1,3-dimethyl-, EINECS 200-385-7, Purine-2,6(1H,3H)-dione, 1,3-dimethyl-, Theophylline, anhydrous (+15 more)
INCI: THEOPHYLLINE
Theophylline (CAS 58-55-9) is a cosmetic cosmetic ingredient functioning as Skin conditioning agent (methylxanthine; promotes microcirculation, lipolysis). NOAEL 7.5 mg/kg bw/day (cross-referenced against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: prohibited; GHS signal word DANGER. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
US NotesCIR Panel concluded safe in present practices of use and concentration ; permitted in US cosmetics
For full compliance data across multiple jurisdictions, use the
Substance Compliance tool.
Safety Data
Margin of Safety, dermal absorption, and sensitization profile summaries for Theophylline.
Calculate MoS for your specific formulation with the
MoS Calculator.
Toxicological Studies
2 study endpoints found for Theophylline. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
Endpoint
Value
Route
Species
Study Type
Source
NOAEL
=30 mg/kg bw/day
injection
Rabbit
reproduction developmental
ToxValDB_ECHA_IUCLID
NOAEL
=124 mg/kg bw/day
oral
Rat
reproduction developmental
ToxValDB_ECHA_IUCLID
GHS Hazard Classification
Globally Harmonized System classification per ECHA C&L inventory and ILO/WHO International Chemical Safety Cards.
Signal Word
DANGER
Pictograms
SkullToxicCancerHealth haz
Hazard Statements
Toxic if swallowed May be harmful if inhaled May cause harm to breast-fed children Causes damage to vascular system and kidneys Causes damage to the kidneys through prolonged or repeated exposure
Short-term Exposure Effects
The substance may cause effects on the heart and central nervous system. This may result in cardiac dysrhythmia and convulsions. The effects may be delayed.
Routes of Exposure
The substance can be absorbed into the body in hazardous amounts by ingestion.
Pre-Calculated Safety Assessment
Pre-calculated NOAEL → SED → MoS audit trail for Theophylline across SCCS product categories, with measured dermal absorption where available.
EPA ToxValDB — Toxicity Values
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
Endpoint
Value
Species
Route
Duration
Source
LC50
>6700 mg/m3
Rat
inhalation
-
ECHA IUCLID
LD50
>2000 mg/kg
Rat
dermal
acute
ECHA IUCLID
LOAEL
=37.5 mg/kg-day
Rat
oral
subchronic
ECHA IUCLID
LOAEL
=126 mg/kg-day
Mouse
oral
-
ECHA IUCLID
LOAEL
=126 mg/kg-day
Mouse
oral
-
ECHA IUCLID
LEL
=75 mg/kg-day
Rat
oral
chronic
ToxRefDB
LEL
=125 mg/kg-day
Rat
oral
chronic
ToxRefDB
LEL
=75 mg/kg-day
Rat
oral
chronic
ToxRefDB
LEL
=37.5 mg/kg-day
Rat
oral
chronic
ToxRefDB
LEL
=225 mg/kg-day
Mouse
oral
chronic
ToxRefDB
IARC Carcinogenicity
International Agency for Research on Cancer (WHO) monograph evaluation.
IARC Group
3
Volume
51
Evaluation Year
1990
EU CLP Annex VI Harmonized Classification
Legally binding harmonized classification per Regulation (EC) No 1272/2008 (CLP) Annex VI.
Signal Word
Danger
Pictograms
Health Hazard
Hazard Class and Category
Repr. 1B
Hazard Statements
H360D
Inserted via ATP: ATP18
ECHA REACH Registration
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Registration Type
Full
Tonnage Band
1 - 10 tonnes
Substance Type
SUBSTANCE; GROUP
SVHC Candidate
No
Hazard classification:Restricted (Annex XVII)
EU CosIng Annex Listing
European Commission CosIng database Annex references per Regulation (EC) No 1223/2009.
Annex II — Prohibited
Ref: 1710
(EU) 2023/1490
Expanded Jurisdictional Detail
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
SA Saudi SFDA (II - Prohibited)
ASEAN Cosmetic Directive (II)
Ref: A1137
Additional Jurisdictional Restrictions (2)
Jurisdiction
Status
Max %
Product Type
CA
banned
-
-
ASEAN
banned
-
All cosmetic products prohibited
Additional Ingredient Properties
1 property record from structured ingredient metadata.
Safety and regulatory annotations from PubChem (NCBI) aggregated sources.
Safety (6)
Carcinogen Classification
3, not classifiable as to its carcinogenicity to humans. (L135)
Source: Toxin and Toxin Target Database (T3DB)
Carcinogen Classification
Theophylline | Group 3: Not classifiable as to its carcinogenicity to humans | Volume 51: (1991) Coffee, Tea, Mate, Methylxanthines and Methylglyoxal
Source: International Agency for Research on Cancer (IARC)
Carcinogen Classification
Theophylline | TR-473: Toxicology and Carcinogenesis Studies of Theophylline in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies) (1998 ) | 12/11/96 | No Evidence | No Evidence | No Evidence | No Evidence | Under the conditions of these 2-year gavage studies, there was no evidence of carcinogenic activity of theophylline in male or female F344/N rats administered 7.5, 25, or 75 mg/kg.
Source: NTP Technical Reports
Evidence for Carcinogenicity
Evaluation: There is inadequate evidence for the carcinogenicity in humans of theophylline. There is inadequate evidence for the carcinogenicity in experimental animals of theophylline. Overall evaluation: Theophylline is not classifiable as to its carcinogenicity to humans (Group 3).
Source: Hazardous Substances Data Bank (HSDB)
Endocrine Disruptors
Potential endocrine disrupting compound
Source: NORMAN Suspect List Exchange
Function Categories & List Membership
Cosmetic/Chemical Function Categories
HumectantPharmaceuticalSoftener and conditioner
Expert Verdict
Expert safety assessment and concern-level summary for Theophylline.
Theophylline has a safety rating of "MODERATE" in our database. EU status: prohibited. US status: permitted. 2 toxicological study endpoint(s) are available in our database.
Is Theophylline allowed in the EU?
Theophylline EU regulatory status: prohibited. This is based on EU Regulation 1223/2009 and its amendments.
What does Theophylline do in cosmetics?
Theophylline functions as: Skin conditioning agent (methylxanthine; promotes microcirculation, lipolysis). It is classified as a cosmetic ingredient in our database. CAS number: 58-55-9.
What is the NOAEL for Theophylline?
The NOAEL (No Observed Adverse Effect Level) for Theophylline is =30 mg/kg bw/day based on a reproduction developmental study via injection route in Rabbit. A total of 2 study endpoints are available. Source: ToxValDB_ECHA_IUCLID.
Is Theophylline classified as hazardous under GHS?
Theophylline carries a GHS signal word of "DANGER". Hazard statements: Toxic if swallowed May be harmful if inhaled May cause harm to breast-fed children Causes damage to vascular system and kidneys Causes damage to the kidneys through prolonged or repeated exposure. This classification is based on the ILO/WHO International Chemical Safety Card and ECHA C&L inventory data. Note: GHS classification applies to the pure substance — at cosmetic use concentrations, hazard thresholds may not be met.
Is Theophylline used outside cosmetics?
Theophylline also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Does Theophylline have different safety status in cosmetics vs industrial chemicals?
Theophylline is prohibited in EU cosmetics but has active industrial GHS classifications (H301, H302, H361, H362, H370, H372, H402, H360D).
Compliance Tools
Check Theophylline compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.